With the stock's price at Rs 3222.50, Torrent Pharmaceuticals' performance reflects its position in the pharmaceutical sector.

The drug regulators in the country have reported a significant jump in the number of Not of Standard Quality (NSQ) drug samples in the routine regulatory surveillance activity during the month of ...

Q4 Results May 20, 2025 updates: Find all the latest Q4 results 2025 updates for Hindalco Industries, Torrent Pharmaceuticals, Gland Pharma, Solar Industries India, Dixon Technologies, Whirlpool of ...

Benchmark NSE Nifty50 index ended down 203.75 points at 24609.7, while the BSE Sensex stood down 644.64 points at 80951.99.

The rally is being fuelled by solid quarterly results and a string of optimistic fiscal 2026 outlooks from leading drugmakers.

Return on investment - most recent fiscal year 19.20 ...

India’s branded pharma market is under pressure as Jan Aushadhi and other generic channels gain momentum, impacting volume ...

An eight-member panel voted unanimously against wider use of Pfizer’s Talzenna in advanced prostate cancer. Elsewhere, U.K.

Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biopharmaceutical company developing therapeutics that use its INTASYL® siRNA gene silencing technology designed to make the body's ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Mankind Pharma Ltd., incorporated in the year 1991, is a Small Cap company (having a market cap of Rs 1,05,174.52 Crore) operating in Pharmaceuticals sector. Mankind Pharma Ltd. key Products/Revenue ...

Bonus Sep 15, 2005 Sep 17, 2005 Jul 18, 2005 Bonus Ratio: 1 share(s) for every 2 shares held Rights Jan 09, 1995 Feb 01, 1995 Mar 15, 1995 Rights ratio: 1 share for every 1 held at a price of Rs 40.0 ...